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56 The Journal of Thoracic and Cardiobjective: Persistent air leak is among the most common complications after
ulmonary resection, leading to prolonged hospitalization and increased costs. At
resent there is not yet a consensus on their treatment.
ethods: During a 7-year experience, 21 patients submitted to pulmonary resection
ere postoperatively treated with an autologous blood patch for persistent air leaks.
ersistent air leaks were catalogued twice daily according to the classification
reviously reported by Cerfolio and associates. Chest radiographs showed a fixed
leural space deficit in 18 (86%) patients. A total of 50 to 150 mL of autologous
lood was drawn from the patient and injected into the chest tube, which was
emoved 48 hours after cessation of the air leak.
esults: We observed a 4% incidence of persistent air leaks after pulmonary
esection in our series. Persistent air leaks were categorized as follows: 14% forced
xpiratory, 57% expiratory, 29% continuous, and 0% inspiratory. The mean dura-
ion of prolonged air leaks was 11 days after surgery. In 81% of the cases examined,
blood patch was only carried out once and gave successful results within 24 hours.
n the remaining 19% of cases, the air leak ceased within 12 hours after the second
rocedure. Mean hospital stay was 15 days. In our experience this procedure had a
00% success rate.
onclusions: Pleurodesis with an autologous blood patch is well tolerated, safe, and
nexpensive. This procedure is an effective technique for treatment of postoperative
ersistent air leaks, even in the presence of an associated fixed pleural space deficit.
ersistent air leak (PAL), defined as an air leak lasting more than 7 days, is
among the most common complications after pulmonary resection, with an
incidence of 3% to 25%.1-8 The resulting prolonged hospitalization h
egative economic effects, delays adjuvant treatment, and may have neg
onsequences on morbidity.
Pleurodesis has been performed by infusion of talc, bacterial components
OK432), antibiotics (tetracycline, doxycycline), and anticancer agents (mitomycin,
driamycin) with a success rate ranging from 60% to 94%.9-12 In this article w
iscuss our 7-year experience during which autologous blood patch pleurodesis was
dopted as a successful technique in 21 patients with PAL after pulmonary
esection.
atients and Methods
etween January 1999 and February 2006, 21 patients (19 men and 2 women) who underwent
horacic surgical treatment were submitted to autologous blood patch pleurodesis to treat
ersistent air leakage. This allowed us to obtain institutional review board approval to
erform this procedure.
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G
TSThe median age at the time of surgery was 67 years (mean
1 years, range 22-83 years). Nineteen (90%) patients had a his-
ory of cigarette smoking, 13 (62%) had a past medical diagnosis
f emphysema, and 6 (29%) had a history of steroid use (10 mg
f prednisone per day for at least 1 month before surgical
reatment).
The following operations were performed: pulmonary resection
or lung cancer in 14 (67%) patients, decortication for empyema in
(10%) patients, and lung volume reduction surgery for emphy-
ema in 5 (23%) patients. Thirteen patients with lung cancer
nderwent lobectomies and 1 patient had a bilobectomy.
Air leaks were catalogued twice daily according to the classi-
cation reported by Cerfolio and associates2 as expiratory, forced
xpiratory, inspiratory, or continuous. During the postoperative
eriod, chest physiotherapy and incentive spirometry were carried
ut on all patients, and bronchodilators were also used when
ecessary.
On the basis of results from previous randomized trials, chest
ubes were always placed to water seal 48 hours after surgery
ecause this method is more efficient than wall suction for stop-
ing air leaks.2,13 Pneumothorax developed in 18 patients, who
ubes were then replaced on 10 cm H2O of wall suction.
An air leak that persisted for more than 7 days was defined as
“prolonged air leak.” As a matter of principle, an autologous
lood patch was used for all patients with PAL after 10 postoper-
tive days.
Chest radiographs at the time of pleurodesis showed a fixed
leural space deficit for inadequate expansion capability of the
emaining lobe(s) to fill the hemithorax in 18 (85%) patients.
A total of 50 to 150 mL of peripheral venous autologous blood
as drawn from the patient and injected into the chest tube (32F)
ith a 100-mL syringe under aseptic conditions. Blood was not
eparinized. No sedation or analgesia was required. The tube was
ot clamped, but the extension tubing was draped 60 cm over the
atient to prevent blood leaving the pleural space but allowing air
o be evacuated. The patient’s position on the bed was changed
everal times during a 1-hour period to help blood distribution into
he pleural space. After 6 hours the water seal was reviewed to
heck for air leak. The next day, a chest radiograph was carried
ut. In those cases in which the blood patch failed and the air leak
ontinued, the procedure was repeated after 48 hours.
The chest tube was removed 48 hours after cessation of air leak,
nd in those patients in whom pleural drainage was less than 200
L it was removed after only 24 hours. After chest tube removal,
ll patients were monitored for clinical and radiologic evidence of
neumothorax or empyema. All data are reported with medians
nd ranges.
esults
he incidence of PAL after pulmonary resection in our
xperience was 4%. The leaks were classified as forced
Abbreviations and Acronyms
PAL persistent air leakxpiratory in 3 (14%) patients, expiratory in 12 (57%), and t
The Journal of Thoracicontinuous in 6 (29%); no cases of inspiratory air leak were
ecorded. Mean duration of PAL was 11 days after surgery
median 11 days, range 5-13 days) (Table 1).
The lung was completely expanded before application of
he blood patch in 3 (14%) patients, 18 (86%) had a fixed
leural space deficit, and 5 (24%) had enlarging subcutane-
us emphysema at the time of pleurodesis.
The amount of blood ranged from 50 mL (2 patients, 9%)
ABLE 1. Summary of patient data
haracteristics No. Range Mean Median
atients
Male 19 (90%)
Female 2 (10%)
Age (y) 22-83 61 67
Smoking 19 (90%)
Chronic obstructive
pulmonary disease
13 (62%)
Steroids 6 (29%)
iagnosis
Lung cancer 14 (67%)
Enphysema 5 (23%)
Empyema 2 (10%)
nterventions
Lobectomy 13 (62%)
Bilobetomy 1 (5%)
Lung volume reduction 5 (23%)
Decortication 2 (10%)
ir leaks
Forced expiratory 3 (14%)
Expiratory 12 (57%)
Inspiratory 0 (0%)
Continuous 6 (29%)
lood (mL)
50 2 (10%)
100 6 (29%)
150 13 (61%)
o. of injections
1 17 (81%)
2 4 (19%)
ead pleural space 18 (85%)
ir leak after operation (d) 5-13 11 11
ir leak after blood patch (h)
One injection 6-24 11 12
Two injections 6-12 10 12
ube after blood patch (d) 2-6 2.8 3
ospitalization (d)
Postoperative 8-31 16 17
After blood patch 2-9 4 3
Total 10-44 16 15
ajor complications 0 (0%)
inor complications
Fever 2 (10%)
Prolonged pleural effusion 1 (5%)
elapse 0 (0%)o 100 mL (6 patients, 29%) and 150 mL (13 patients, 61%).
and Cardiovascular Surgery ● Volume 132, Number 3 557
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G
TSn 17 (81%) patients one injection was sufficient to seal the
AL; 4 (19%) patients (2 with 50 mL and 2 with 100 mL)
equired two injections because the first was not successful.
The blood patch was carried out once on 17 (81%)
atients, and within 12 hours no air leak was detected in the
ater seal in 15 (88%) of them; in the other 2 patients
uccess was achieved within 24 hours (mean 15 hours,
edian 12 hours, range 6-24 hours). The procedure was
epeated a second time in 4 (19%) patients 48 hours after
pplication of the first blood patch, and air leak ceased
ithin 12 hours. Chest tubes were removed 48 hours after
he confirmation of no air leak. One patient was discharged
ith a Heimlich valve for prolonged pleural drainage (200
L per day), which was removed 7 days after pleurodesis.
o pain, respiratory difficulty, cough, or major side effects
ere observed during the procedure. No significant decrease
n hematocrit value was observed after removal of blood.
o patient required a reoperation for air leak. No late
mpyema or other major morbidity was observed. In 2
atients submitted to decortication for empyema, low-grade
ever lasting 1 day was observed after blood patch pleu-
odesis. One patient had to be transferred to an intensive
espiratory unit for no invasive positive-pressure ventila-
ion. The median hospital stay was 15 days (mean 16 days,
ange 10-44 days). Follow-up was completed in all patients
ith a median duration of 25 months (range 6-86 months).
one has had recurrent pneumothorax or empyema. No
perative mortality was observed. After 3 months, chest
-ray films confirmed complete re-expansion of the lung
nd no pleural drainage in all 21 patients. In no instances in
ur experience was this procedure unsuccessful.
iscussion
he incidence of PAL associated with pneumothorax and
ausing prolonged hospitalization in patients requiring pul-
onary resection is 15.2%.1
Air leak after lobectomy usually ceases spontaneously if
dequate re-expansion of the remaining lung is established.
t is frequently treated by prolonged aspiration and use of
he Heimlich valve, and most authors recommend pleurode-
is with sclerosing agents such as tetracycline, talc, or
K4329-12 before resorting to a rethoracotomy. Howev
hemical pleurodesis often fails and PAL with a fixed
leural space deficit remains. Furthermore, without ade-
uate re-expansion, the sclerosing agent itself may prevent
e-expansion of the remaining lung because of thickening of
he visceral pleura.
Autologous blood patch pleurodesis has been reported in
he literature by many authors as a procedure for PAL and
neumothorax with encouraging results. Robinson14 was
he first in 1987 to report an 85% success rate with this
echnique in chronic or recurrent spontaneous pneumotho-
aces. Subsequently, other authors reported their experience t
58 The Journal of Thoracic and Cardiovascular Surgery ● Septen short series of PAL after pulmonary resection or sponta-
eous pneumothorax.15-23
Our retrospective experience is the largest reported in the
iterature using this procedure for treating PAL after pul-
onary resection. We observed a success rate of 100% in 21
atients.
A bronchoscopy can be warranted to rule out a broncho-
leural fistula that requires different treatment, such as
ndoscopic or surgical closure.24
Timing to perform blood patch pleurodesis ranges be-
ween 5 days and several weeks in the literature.15,21,23 At
he beginning of our experience we performed blood patch-
ng after 10 days, but later we observed that if an air leak
as present on postoperative day 5 there was a high prob-
bility (87% in our series) that it would be present on
ostoperative day 8 as well, so we proposed to use blood
atch pleurodesis after 5 to 7 days to reduce the probability
f pleural infection and to minimize delay of discharge.
Some authors reportedly inject no more than 50 mL of
utologous blood to avoid introducing into the pleural space
n ideal medium for bacteria that may be complicated by
mpyema.23 The first 2 patients were treated by introduc
0 mL of blood, but a second injection was necessary
ecause the first procedure did not result in successful
ealing. Therefore, we subsequently increased to 100 mL of
lood, and 2 of 6 patients required a second patch. In the last
3 patients of our series, we introduced 150 mL of blood
irectly with the first patch, and this procedure resulted in a
omplete success rate without any septic complication. We
ow recommend 150 mL of blood for all patients. Other
uthors exclude the use of this treatment in patients who
ave air leaks with incomplete lung re-expansion or residual
leural space because they fear that blood may represent a
ulture medium for bacteria with a high risk of empyem23
e want to underline that PAL in itself, even without a blood
atch, increases the risk of empyema and that only one expe-
ience reports empyema after blood patch pleurodesis—a
urkish article reporting 3 cases (rate of 9%).20 In our
eries, chest radiographs evidenced a fixed pleural space
eficit in 18 (86%) patients at the moment of pleurodesis, all
f whom were treated by a blood patch with success and
ithout complication.
The sclerosing effect of blood is not as potent as that of
ther agents, but its mechanism may be based on three
actors working together: irritation of pleural surfaces, re-
uction of fixed pleural space deficit by clot, and oblitera-
ion of alveolar-pleural fistulas by fibrogenic activity and
atch-effect that contribute to re-expansion of the remaining
ung.
Williams and Laing25 reported a case of tension pne-
othorax after blood patch pleurodesis using 12F (2.6 mm
nternal diameter) intercostal catheters. We did not observe
his complication in our series after pulmonary resection,
mber 2006
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G
TSerhaps because we used only chest tubes with a 32F
iameter that were not clamped after instillation of blood
ut were raised above the patient, so that occlusion was not
bserved in any patient.
Blood pleurodesis has low costs, acceptable side effects,
nd a high rate of success. In our opinion this procedure
hould be considered in PAL before a reoperation, in pa-
ients with high risk of surgical morbidity and mortality, and
efore using other sclerosing agents. The blood patch is also
ffective in those difficult cases in which other sclerosing
gents fail, probably because of residual pleural spaces.
Our experience confirms the success obtained with this
rocedure in previous cases as a treatment of PAL after
ulmonary resection. We advocate randomized controlled
rials to ascertain many unclear points of discussion, such as
election of patients, right timing, optimal quantity of blood,
nd comparison of results and costs with other procedures.
We thank Dr Anna Pierini for her help in preparing the manu-
cript.
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